Capital Fund Management (CFM)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.4M | Sell |
|
|||||
|
2025
Q2 | $25.6M | Buy |
|
|||||
|
2025
Q1 | $19.4M | Buy |
|
|||||
|
2024
Q4 | $14.3M | Sell |
|
|||||
|
2024
Q3 | $12.9M | Buy |
|
|||||
|
2024
Q2 | $7.84M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $5.86M | Buy |
|
|||||
|
2020
Q4 | $1.9M | Sell |
|
|||||
|
2020
Q3 | $2.18M | Buy |
|
|||||
|
2020
Q2 | $2.36M | Sell |
|
|||||
|
2020
Q1 | $2.05M | Buy |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $585K | Buy |
|
|||||
|
2019
Q1 | $292K | Sell |
|
|||||
|
2018
Q4 | $1.79M | Buy |
|
|||||
|
2018
Q3 | $1.39M | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $6.35M | Buy |
|
|||||
|
2016
Q4 | $1.11M | Buy |
|
|||||
|
2016
Q3 | $656K | Sell |
|
|||||
|
2016
Q2 | $3.5M | Buy |
|
|||||
|
2016
Q1 | $333K | Sell |
|
|||||
|
2015
Q4 | $5.24M | Sell |
|
|||||
|
2015
Q3 | $12.3M | Buy |
|
|||||
|
2015
Q2 | $3.41M | Buy |
|